These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pleconaril. A broad spectrum antipicornaviral agent. Rogers JM; Diana GD; McKinlay MA Adv Exp Med Biol; 1999; 458():69-76. PubMed ID: 10549380 [No Abstract] [Full Text] [Related]
3. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials. Hayden FG; Herrington DT; Coats TL; Kim K; Cooper EC; Villano SA; Liu S; Hudson S; Pevear DC; Collett M; McKinlay M; Clin Infect Dis; 2003 Jun; 36(12):1523-32. PubMed ID: 12802751 [TBL] [Abstract][Full Text] [Related]
4. Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: efficacy and tolerability in phase II clinical trials. Hayden FG; Coats T; Kim K; Hassman HA; Blatter MM; Zhang B; Liu S Antivir Ther; 2002 Mar; 7(1):53-65. PubMed ID: 12008788 [TBL] [Abstract][Full Text] [Related]
5. Single-dose pharmacokinetics of a pleconaril (VP63843) oral solution and effect of food. Abdel-Rahman SM; Kearns GL Antimicrob Agents Chemother; 1998 Oct; 42(10):2706-9. PubMed ID: 9756781 [TBL] [Abstract][Full Text] [Related]
7. Single oral dose escalation pharmacokinetics of pleconaril (VP 63843) capsules in adults. Abdel-Rahman SM; Kearns GL J Clin Pharmacol; 1999 Jun; 39(6):613-8. PubMed ID: 10354965 [TBL] [Abstract][Full Text] [Related]
8. Single dose pharmacokinetics of pleconaril in neonates. Pediatric Pharmacology Research Unit Network. Kearns GL; Bradley JS; Jacobs RF; Capparelli EV; James LP; Johnson KM; Abdel-Rahman SM Pediatr Infect Dis J; 2000 Sep; 19(9):833-9. PubMed ID: 11001105 [TBL] [Abstract][Full Text] [Related]
9. Single-dose pharmacokinetics of a pleconaril (VP63843) oral solution in children and adolescents. Pediatric Pharmacology Research Unit Network. Kearns GL; Abdel-Rahman SM; James LP; Blowey DL; Marshall JD; Wells TG; Jacobs RF Antimicrob Agents Chemother; 1999 Mar; 43(3):634-8. PubMed ID: 10049279 [TBL] [Abstract][Full Text] [Related]
10. [New antivirals for respiratory tract viruses]. Le Moing V Presse Med; 1999 Nov; 28 Suppl 3():22-4. PubMed ID: 10605465 [TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy evaluation of pleconaril for treatment of the common cold. Fleischer R; Laessig K Clin Infect Dis; 2003 Dec; 37(12):1722. PubMed ID: 14689362 [No Abstract] [Full Text] [Related]
14. [Pleconaril, a new aniviral drug with activity against picornavirus]. Reina J; Ballesteros F Rev Esp Quimioter; 2000 Sep; 13(3):257-62. PubMed ID: 11086273 [No Abstract] [Full Text] [Related]
15. Clinical activity of pleconaril in an experimentally induced coxsackievirus A21 respiratory infection. Schiff GM; Sherwood JR J Infect Dis; 2000 Jan; 181(1):20-6. PubMed ID: 10608746 [TBL] [Abstract][Full Text] [Related]
16. Selective inhibitors of picornavirus replication. De Palma AM; Vliegen I; De Clercq E; Neyts J Med Res Rev; 2008 Nov; 28(6):823-84. PubMed ID: 18381747 [TBL] [Abstract][Full Text] [Related]
17. The need for treatment against human parechoviruses: how, why and when? Wildenbeest JG; Harvala H; Pajkrt D; Wolthers KC Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1417-29. PubMed ID: 21133666 [TBL] [Abstract][Full Text] [Related]
18. Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses. Pevear DC; Hayden FG; Demenczuk TM; Barone LR; McKinlay MA; Collett MS Antimicrob Agents Chemother; 2005 Nov; 49(11):4492-9. PubMed ID: 16251287 [TBL] [Abstract][Full Text] [Related]
19. Viral respiratory infections due to rhinoviruses: current knowledge, new developments. Fendrick AM Am J Ther; 2003; 10(3):193-202. PubMed ID: 12756426 [TBL] [Abstract][Full Text] [Related]
20. Presentation, diagnosis, and management of enterovirus infections in neonates. Abzug MJ Paediatr Drugs; 2004; 6(1):1-10. PubMed ID: 14969566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]